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Atherosclerosis is initiated when lipoproteins bind to proteoglycans (PGs) in arterial 
wall. The binding is mediated by apolipoprotein apoB-100 and/or apoE, both of which 
have binding affinity toward heparin. We developed covalently bound heparin 
coatings for APTES-modified silica capillary and SiO2 chips and carried out capillary 
electrochromatography (CEC) and quartz crystal microbalance (QCM) studies on the 
interactions of heparin with selected peptide fragments of apoB-100 and apoE and, for 
CEC, also with low and high density lipoproteins (LDL and HDL), the latter with and 
without apoE. The peptides are known to mediate interactions of HDL and LDL with 
arterial PGs. Interactions and affinities were expressed in CEC as retention factors 
and reduced mobilities and in continuous flow QCM technique as affinity constants. 
Both techniques showed heparin interactions to be stronger with apoB-100 peptide 
than with apoE peptide fragment, and they confirmed that the sulfate groups in 
heparin play an especially important role in interactions with apoB-100 peptide 
fragment. In addition, CEC confirmed the importance of sulfate groups of heparin in 
interactions between heparin and LDL and between heparin and apoE-containing 
HDL. CEC and QCM acted as excellent platforms to mimic these biologically 
important interactions, with small sample and reagent consumption. 
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The specific interactions between human plasma lipoproteins and proteoglycans 
(PGs), which are structural components of the extracellular matrix (ECM) of the 
arterial wall, play an important role in the development of atherosclerosis [1-5]. PGs 
contain glycosaminoglycans (GAGs), which are unbranched carbohydrate polymers 
composed of repeating disaccharide units and which are covalently attached to a 
protein core (by a glycosidic linkage). The GAGs bear negative charges due to sulfate 
and carboxylic groups. The most common GAGs are heparin, chondroitin sulfate, 
dermatan sulfate, heparan sulfate, and hyaluronic acid.  
 
Lipoproteins are nanometer-sized particles (between 11 and 80 nm), which carry 
lipids in circulation. High concentrations of low-density lipoprotein (LDL) particles 
are considered as a main cause of human atherosclerosis. Indeed, there is strong 
experimental evidence that LDL particles may initiate the development of 
atherosclerotic lesions [4]. In this scenario, LDL enters the subendothelial space of the 
arterial wall, where it is retained, via ionic interactions, when the positively charged 
lysine and arginine residues of apolipoprotein (apo) B-100 interact with the negatively 
charged sulfate and carboxyl groups of the glycosaminoglycan (GAG) chains of the 
proteoglycans.  High density lipoprotein (HDL) particles, containing apoA 
lipoproteins, are considered antiatherogenic since they do not interact with GAGs and, 
accordingly, are not retained by arterial wall proteoglycans. However, a fraction of 
HDL particles contain apoE, which, like apoB-100, has domains of positively charged 
residues that have been shown to mediate the binding of HDL to GAGs [6].  
In this study, we analyzed the heparin binding of LDL and of HDL (containing or not 
containing apoE), and of two positively charged peptides corresponding to relevant 
sequences of apoB-100 and apoE. The first peptide was a 19 amino acid peptide of 
apoB-100 (3359-3377) with net charge of +6, and the second a 15 amino acid peptide 




lysine and arginine residues, they can selectively interact with the GAG chains of the 
proteoglycans. ApoE has proved to be a strong competitor of apoB-100 for interaction 
with arterial PGs [7]. The residues from 3359 to 3369 in apoB-100 have been shown 
to be the major proteoglycan-binding site in LDL particles [8], and the residues from 
136 to 150 in apoE have been identified by Weisgraber et al. [9] as the 
heparin-binding site of this protein. The helical wheel corresponding to the sequence 
leu-arg-lys-leu-arg-lys-arg-leu-leu-arg (residues 141-150) of apoE is similar in charge 
distribution to that of residues 3359-3369 of apoB-100 [9].  
 
Many techniques, including quantitative frontal elution affinity chromatography [7], 
homogeneous enzyme-based binding assay [10], and surface plasmon resonance [11], 
have been applied for the interaction studies between GAGs and lipoproteins. 
Capillary electrochromatography (CEC) not only offers high resolution separations 
but also great flexibility and the potential for elucidation of the interactions of 
nanodomains of biological importance [12,13].  
 
The quartz crystal microbalance (QCM) is a mass-sensing device belonging to the 
family of acoustic biosensors, whose signal transduction mechanism depends on the 
piezoelectric effect of the quartz crystal. The QCM has been successfully applied to 
the study of a number of biochemical processes, and also to the development of 
biomimetic biosensors and systems [14-16]. Molecules of interest (ligands) are 
directly immobilized on the gold surface, which can be modified for interaction 
studies with specific analytes. The main advantages of the QCM are low mass 
sensitivity and the possibility to follow the kinetics of the binding process.  
 
Our recent demonstration [16] that QCM can be successfully applied for the 
elucidation of interactions between chondroitin-6-sulfate (C6S) and apolipoprotein 




persuaded us to employ QCM with a SiO2 chip as a complementary technique in 
heparin interaction studies carried out by open tubular CEC. In CEC, heparin was 
both directly immobilized and covalently bound onto a capillary inner wall modified 
with 3-aminopropyltriethoxysilane (APTES). The stability of the coating was 
estimated by measuring the electroosmotic flow (EOF) mobilities. The 
APTES–heparin covalent coating procedure was also applied to SiO2 chip surfaces for 
QCM studies. The interactions of heparin with the selected peptide fragments of 
apoB-100 and apoE, and with apoB-100- and apoE-containing human plasma 
lipoproteins, were examined by CEC in terms of reduced mobilities and retention 
factors and by QCM in terms of affinity constants.  
 
2. Materials and methods 
2.1. Materials 
Heparin (H4784), 3-aminopropyltriethoxysilane (APTES), and 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC, E 1769) were 
purchased from Sigma-Aldrich. Dimethyl sulfoxide (DMSO), sodium hydroxide (1.0 
M), and hydrochloric acid (1.0 M) were from Oy FF-Chemical Ab (Yli Ii, Finland), 
phosphoric and acetic acids were purchased from Merck, and NaCl was from JT 
Baker. Sodium acetate was obtained from Fluka (Buchs, Switzerland) and acetone 
was from Mallinckrodt Baker (Deventer, The Netherlands). Peptide fragments of 
apoB and apoE were synthesized at the Meilahti Protein Chemistry Facility and 
analyzed at the Protein Chemistry Core Facility, both at Biomedicum, University of 
Helsinki, Finland.  
 
2.2. Instrumentation 
A Hewlett-Packard 3DCE system (Agilent, Waldbronn, Germany) equipped with a 
diode array detector (detection at 200, 214 and 254 nm) and an air-cooling device for 




response time of 0.1 s. Bare fused silica capillaries were from Composite Metal 
Services Ltd. (Worcestershire, U.K.). Dimensions were 50 µm i.d. and 375 µm o.d. 
The effective length of the capillary was 30.0 cm with a total length of 38.5 cm. A 
Lauda Ecoline Re-104 water bath (Lauda-Königshofen, Germany) was used to control 
the temperature of the autosampler. QCM experiments were carried out with an 
Attana A100 instrument QCM biosensor (Attana AB, Stockholm, Sweden). A Jenway 
3030 pH meter (Jenway, Felsted, UK) and a MeterLab PHM 220 pH meter 
(Radiometer, Copenhagen, Denmark) were used in the pH measurements. Distilled 
water was further purified with a Millipore water purification system (Millipore S.A., 
Molsheim, France). Millipore filters (Bedford, MA, USA) were used for filtering 
background electrolytes (BGEs).  
 
2.3. Methods 
2.3.1. Isolation of LDL particles from human plasma 
Human LDL (d = 1.019-1.050 g/ml) was isolated from the plasma of healthy 
volunteers (Finnish Red Cross) by sequential ultracentrifugation in the presence of 3 
mM ethylenediaminetetraacetic acid (EDTA) [17]. Briefly, solid KBr was added to 
plasma to adjust the density to 1.019 g/ml. The floated VLDL and IDL fractions were 
removed, and the density of the supernatant solution was adjusted to 1.050 g/ml with 
solid KBr. After ultracentrifugation for 72 h at 35,000 rpm in a Beckman Coulter type 
50.2 Ti rotor (148,000gmax), LDL was recovered from the top of the centrifuge tubes, 
recentrifuged (d=1.060 g/ml) for 24 h at 35,000 rpm in a Beckman Coulter-type 80 Ti 
rotor (115,000gmax), and dialyzed extensively against LDL buffer (1 mM EDTA and 
150 mM sodium chloride in water, pH 7.4, adjusted with sodium hydroxide). The 
amount of LDL is expressed in terms of its protein concentration, which was 






2.3.2. Isolation of spherical HDL2 particles from human plasma 
Human HDL2 (d = 1.063–1.125 g/ml) particles were isolated by sequential density 
ultracentrifugation [19]. Solid KBr was used to adjust the densities in each 
centrifugation step. The HDL subclasses were washed by reflotation at their upper 
density (1.125 g/ml for HDL2). All of the centrifugation steps were carried out at 
50,000 rpm in a Beckman Ti 50.2 rotor (302,000 gmax) for 40 h at +5. HDL and its 
subclasses were dialyzed against sodium phosphate buffer (20 mM 
phosphate-buffered saline, pH 7.4) containing 140 mM NaCl to remove KBr. The 
dialyzed HDL subclasses were stored at +4˚ C. Protein and lipid compositions of the 
isolated HDL particles (%, w/w) were determined by standard methods [20]. 
 
2.3.3. Purification of HDL with and without apoE 
HDL with and without apoE was purified by heparin-affinity chromatography by a 
modification of the reported method [21]. Briefly, HiTrap Heparin-Sepharose column 
(1 mL, Amersham Biosciences AB, Uppsala, Sweden) was equilibrated with 5 mM 
Tris-HCl / 50 mM NaCl, pH 7.4, with a flow rate of 0.5 mL/min. Just before 
application to the column, solid MnCl2 was added to the HDL solution to give a final 
Mn2+ concentration of 25 mM, and the column was equilibrated with 5 mM Tris-HCl / 
50 mM NaCl, pH 7.4, containing 25 mM MnCl2. Next, HDL (1-2 mg as protein, to 
which MnCl2 had been added) was applied to the column, and the column was washed 
with 5 mM Tris-HCL / 50 mM NaCl / 25 mM MnCl2, pH 7.4, until the A280 dropped 
to the baseline. The apoE-free HDL particles not bound to heparin could then be 
collected. The heparin-bound apoE-containing HDL was detached from heparin and 
eluted with 5 mM Tris-HCl / 100 mM NaCl, pH 7.4, and collected in 1 mL fractions. 
The non-bound fractions (representing apoE-free HDL) and the bound fractions 
(representing apoE-containing HDL) were pooled, dialyzed separately against PBS, 
and stored at +4oC until use. ApoE was analyzed in isolated HDL pools by 





2.3.4. Sample and buffer preparation 
Phosphate buffers (I=20 mM) at pH 7.4, 6.5 and 5.5; phosphate buffers (I=20 mM) at 
pH 7.4 and 5.5 containing 25 mM NaCl, and acetate buffers (I=20 mM) at pH 4.0, 4.5 
and 5.0 were prepared, and the pH was adjusted with 1.0 M NaOH, 1.0 M HCl or 
100% acetic acid, respectively. Before use, the buffers were filtered through 0.45-µm 
Millipore filters using a Millipore vacuum system. The stock solutions of DMSO (1% 
v/v) and EDC (4 mg/mL) were prepared in Milli-Q water. The solutions of heparin 
(0.1 – 20 mg/mL) used for the non-covalent coating of the capillary were diluted in 
water, and the heparin solution (3 mg/mL) containing EDC (0.125 mg/mL) that was 
used for the covalent coating was prepared in phosphate buffer (I=20 mM), pH 7.4. 
The heparin-EDC mixture was prepared 16 h before use. APTES solution (4%, v/v) 
was prepared in acetone. The stock solutions of peptide fragments (1 and 2 mg/mL) 
were prepared by dissolving their powders in MilliQ water. Before injection, the 
peptide stock solutions were diluted in the phosphate buffer (I=20 mM) at pH 7.4 for 
CEC and in phosphate buffer (I=20 mM) pH 7.4 containing 25 mM NaCl for QCM to 
give final concentrations of 0.25-0.5 mg/mL for CEC and 8-50 mg/mL for QCM. The 
regeneration solution for QCM (0.4 M NaCl) was prepared in Milli-Q water. The 
DMSO and peptide solutions were stored at + 4 oC and – 20 oC, respectively. 
 
2.3.5. Coating procedures  
2.3.5.1. Treatment of fused silica capillaries 
The capillary was flushed with 1 M HCl for 10 min and water for 5 min, and then 
with 1 M NaOH for 15 min and water for 5 min. The capillary was equilibrated with 
BGE for 10 min. Between runs, the capillary was rinsed with 0.1 M NaOH, water and 
BGE for 2 min each. 
 




The procedure was modified from the method described by Cifuentes et al. [22]. The 
first step was rinsing the capillary with 5 M HCl for 30 min, water for 30 min, 5 M 
NaOH for 30 min. and water for 30 min. The capillary was purged with N2 gas at 265 
˚C during 2 h and then rinsed for 1 h with a solution containing 5 µL of acetic acid 
and 5 µL of 3-(trimethoxysilyl)propyl methacrylate in 1 mL of methanol. Afterwards, 
the capillary was washed with methanol during 30 min. In a final step the capillary 
was rinsed with a solution of polyacrylamide containing N,N,N’,N’-tetra 
methylethylendiamine (TEMED) and ammonium persulfate (APS), and immediately 
afterwards it was filled with the acrylamide+APS+TEMED solution. The capillary 
was sealed at both ends and left to polymerize over night. After polymerization was 
compleated the capillary was washed with water and buffer. 
 
2.3.5.3. Coating of capillary and SiO2 chip with APTES 
The coating with APTES was optimized for fused silica capillaries, and the optimized 
coating procedure was then applied to the SiO2 chip surfaces used in QCM 
measurements. 
 
Before coating, the fresh capillary was pretreated-treated in the following steps: 15 
min capillary flush with 1 M NaOH, 15 min flush with deionized water, and 15 min 
flush with acetone at pressure of 940 mbar. After preconditioning, the APTES coating 
was applied to the capillary inner surface as follows: the capillary was flushed with 
4% (v/v) APTES solution in acetone at 50 mbar for 30 min and left to stand filled 
with the silanization solution for 16 h. Then the capillary was flushed with acetone for 
10 min, with water for 5 min, and with phosphate buffer at pH 5.5 for 60 min to 
eliminate the unbound APTES. 
 
SiO2-coated chips were purchased from Attana AB (Stockholm, Sweden). Coating of 




a water bath. Coating was performed in a small vial. APTES coating of the SiO2 
surface was starting with preconditioning. The chip was rinsed with 1 M NaOH for 20 
min, twice with Milli-Q water for 15+15 min, and with acetone for 15 min. After 
preconditioning, the chip was left to react with 4% (v/v) APTES solution for 16 h. 
Postconditioning consisted of rinsing with acetone for 20 min,  with Milli-Q water 
for 15 min, and finally with phosphate buffer (I=20 mM), pH 5.5, and 25 mM NaCl 
for 15 min. 
 
2.3.5.4. Direct immobilization of heparin onto APTES-modified capillary surface 
After preconditioning and coating of the capillary with APTES, the amino-silanized 
capillaries were treated with heparin. Briefly, the capillaries were flushed with 
heparin solutions at 50 mbar for 40 min, left to stand filled with the coating solutions 
for 15-60 min, and flushed with phosphate buffer at pH 7.4 for 15 min. 
 
2.3.5.5. Covalent binding of heparin onto APTES-modified capillary surface and 
SiO2 chip 
APTES–heparin covalent coating was done by a modification of the method described 
by Stege et al. [23]. After APTES coating of the capillary, a solution of heparin (3 
mg/mL) dissolved in 2 ml phosphate buffer, pH 7.4 (I: 20 mM), containing 0.25 mg 
of EDC was passed through the capillary for 1 h. The APTES-coated SiO2 chip was 
left to react with the same solution for 2 h. Finally, the capillary and the chip were 
rinsed with phosphate buffer at pH 7.4 to remove the unbound heparin. 
 
2.3.6. Electroosmotic flow (EOF) measurements 
EOF marker DMSO (0.05%) was used as an indicator of changes in surface charge 
during the coating procedure. The electroosmotic flow (EOF) mobilities were 
employed for estimation of the stability of the coatings. Owing to the very low EOF in 




peptide fragments were measured by the method of Williams and Vigh [24]. Before 
each run, the capillary was flushed with 20 mM BGE at pH 7.4 for 2 min. The 
running conditions were the following: sample injection by pressure at 50 mbar, 
injection time 2 s, voltage +20 kV, and temperature 37 ºC. 
 
2.3.7. Quartz crystal microbalance analysis  
All the QCM experiments were conducted with an Attana A100 QCM biosensor 
(Attana AB, Stockholm, Sweden). The chip consisted of a 0.4-mm thick crystal 
sandwiched between two gold-plated electrodes. An acoustic wave was generated in 
the crystal by applying an oscillating potential through the electrodes. The c-fast 
program was used for sample injection, and frequency shifts due to binding of the 
analyte to the surface were recorded with Attester®. The sample was injected by 
loading the injection loop and then switching the valve so that the sample was 
transported to the sensor surface. After the injection the valve was switched back and 
the running buffer was transported to the surface. 
The APTES–heparin-coated chip was inserted to the instrument and left to stabilize in 
phosphate buffer (I=20 mM), pH 7.4 + 25 mM NaCl, flow rate 25 µl/min. Constant 
flow was generated with a piston pump that transported the buffer to the surface. The 
same phosphate buffer was used as running buffer in all experiments. Peptide 
fragments of apoB-100 and apoE were used as analytes and the interactions were 
studied at 25 and 37 °C. The flow rate and injection volume in all experiments were 
25 µl/min and 35 µl. The chip was regenerated after every analyte injection with 0.4 
M NaCl, injection volume 30 µl.  
 
3. Results and discussion 
Glycosaminoglycans play important biological roles through their interactions with 
other macromolecules. They specifically interact with proteins such as apoE and 




[25]. About fifty years ago, it was suggested that the binding of circulating LDL with 
GAGs in the inner wall of arteries is a key process in the development of 
atherosclerosis [26,27]. ApoE, a protein component of a small fraction of HDL, acts 
as a ligand for the LDL receptor. Further, by interacting with the heparan sulfate on 
the cell surface, apoE, like apoB-100, plays an important role in regulating the 
lipoprotein metabolism and in transporting and redistributing lipids among cells and 
tissues [28,29]. Physiologically, apoE is also a crucial ligand in the clearing of 
chylomicron remnants from the circulation via interaction of apoE with the hepatic 
LRP-1 receptor. The binding sites of apoB-100 and apoE with GAGs have been 
identified and characterized [7]. In both, an abundance of positively charged amino 
acid residues of lysine and arginine are present in the domains responsible for the 
binding. The present study will shed light on the interactions of heparin with two 
carefully selected peptide fragments of apoB-100 and apoE, human low-density and 
high-density lipoproteins, and full-length apoE.  
 
3.1. Development of APTES–heparin coating procedures for fused silica 
capillaries and SiO2 chips 
In previous studies, we have developed various protocols for the immobilization of 
human lipoproteins [30-32] and collagens [13] on the inner surface of fused silica 
capillaries via positively charged amino acid residues and for the immobilization of 
chondroitin-6-sulfate and collagen on carboxyl surface via amine coupling [15,16]. 
The first ones were done to allow interaction studies by capillary electromigration 
techniques and the second ones to allow studies with a quartz crystal microbalance. In 
the present investigation, heparin was covalently and non-covalently coated on fused 
silica capillaries and covalently coated on SiO2 chip surfaces. We have noted in 
previous studies that the immobilization technique may greatly affect the interaction 
strength depending on which functional groups are wasted during the immobilization 




coating on the interactions were clarified by CEC. Different functionalities are lost in 
the covalent and non-covalent coating procedures, allowing more detailed information 
to be obtained about the role of these functionalities in heparin and peptide 
interactions. Because heparin, silica capillary and SiO2 chip surfaces were negatively 
charged, the capillary and chip surfaces were first modified with APTES, which 
through covalent and ionic bonding provided an excellent, positively charged 
platform for the binding of heparin. Coating of the capillary with APTES reversed the 
direction of EOF and resulted in a stable surface, as confirmed by a repeatable EOF 
mobility (RSD 3.05%) (n=6). 
 
3.1.1. APTES–heparin non-covalent coating for CEC 
The non-covalent immobilization of heparin on APTES-coated capillary was based on 
ionic interactions between the positively charged amino groups of APTES and 
negatively charged sulfate and/or carboxylic groups of heparin. We studied the effects 
on the coating of the incubation time employed in the heparin coating, the 
concentration of the heparin, and the pH of the BGE solution. The stability of the 
coating was evaluated by measuring the EOF mobility (n=6).  
 
The stability of the coating improved when the incubation time was increased from 15 
min (RSD of EOF 32.4%, n=6) to 60 min (RSD of EOF 4.5% , n=6). The stability 
was not improved with more than 60 min incubation time, and 60 min incubation time 
was selected for the further studies. 
 
The EOF mobility was increased with heparin concentrations from 0.1 to 3.0 mg/mL. 
Increase in the concentration from 3.0 to 20.0 mg/mL did not improve the EOF 
mobility or stability of the coating further, and since the RSD values of the EOF 





The effect of pH on the stability of the coating was studied from pH 4.5 to 7.4 by 
using phosphate buffer in pH range 6.0-7.4 and acetate buffer in pH range 4.5-5.5. 
The coatings were stable over the whole range. Physiological pH 7.4 was selected for 
the further studies since this is the most relevant value for interactions between 
lipoproteins and glycosaminoglycans during initiation of atherosclerosis. 
 
The stability of the coating, which is important not only for practical reasons but also 
to minimize the amount of heparin required, was tested by measuring the EOF 
mobilities at pH 7.4 and 25 and 37 °C (n=6) on ten successive days. At the end of 
each day, the capillary was rinsed with phosphate buffer (I=20 mM) at pH 7.4 and left 
filled with the same BGE overnight. The EOF did not change significantly over the 
ten-day period, confirming that the coating was stable at 25 and 37 °C for at least ten 
days. The reliability of the measurements was determined by evaluating the 
reproducibility of different, individually coated capillaries. The results demonstrated 
that the capillary-to-capillary reproducibility was good at both 25 and 37 °C.  
 
3.1.2. APTES–heparin covalent coating for CEC capillary and SiO2 chip 
APTES–heparin covalent coating was used to coat both the inner surface of the 
capillary and the SiO2 surface of the QCM chip. In covalent coating, heparin was 
attached to APTES with EDC linker, which reacts with the carboxyl groups in heparin 
and free amine groups on the APTES surface. A stable amide bond is formed, and the 
sulfate groups in heparin are free to interact with analytes.  
 
The stability and the coating-to-coating reproducibility of the APTES–heparin 
covalent coating were evaluated by measuring the mobility of the EOF during 
successive runs. The coating was stable at 37 ˚C for at least ten days, and the RSD of 
0.6% to 1.2% of the EOF mobilities (n=6) in three different capillaries demonstrated 




mobilities at 37 °C in capillaries with covalently bound heparin demonstrated the 
availability, for interaction, of a greater amount of negatively charged groups on the 
heparin surface than on the capillary with electrostatically attached heparin.  
 
The covalent ligand coating, which minimizes heparin losses during the regeneration 
step, was chosen for the QCM experiments. In addition, as noted in the CEC studies, 
fewer negatively charged groups important for interactions were lost when heparin 
was covalently coated onto the chip surface. The APTES–heparin covalent coating 
was stable for one week, after which the binding capacity of the surface weakened 
rapidly and the repeatability of the frequency shifts decreased.  
 
3.2. Affinity of heparin with peptide fragments expressed as retention factors 
and affinity constants  
The 19 amino acid peptide of apoB-100 and the 15 amino acid peptide of apoE were 
selected as analytes for the interaction studies because they are present in the 
sequences involved in the PG interactions of LDL and HDL, respectively. These 
peptides highlight the crucial role of the positively charged amino acids arginine and 
lysine in the interactions. Retention factors and affinity constants (Ka) were calculated 
to describe the interactions between the peptide fragments used as analytes and 
heparin immobilized on the surface of the capillary or SiO2 chip.  
 
The retention factor k can be used to describe the interactions between the analytes 
and the coatings in capillary electrochromatography:  
 





where migration times of the analyte (tm) and an unretained component (teo) describe 
the ratio of the time the peptide stays in the stationary phase to the time it is in the 
mobile phase. Equation 1 is suitable for calculating the retention factor of uncharged 
compounds. For charged analytes, which bind reversibly to the open tubular 
stationary phase, Rathore and Horvath [33] have introduced k′ as a measure of 
retention. Equation 2 can be used for both uncharged and charged analytes:  
 
             (2) 
                             
where the velocity factor k′e is uep/ueo (uep is the electrophoretic mobility of the analyte 
in the uncoated capillary and ueo is the EOF in the coated capillary). Wiedmer et al. 
[34] transformed Eq. 2 into the more convenient form (3) 
 
         (3) 
 
where tm′ and teo′ are migration times of the analyte and the EOF in the uncoated 
capillary, respectively. We used Equation 3 for measurement of the retention factors 
for peptide fragments. Because the retention factors obtained for the peptide 
fragments in uncoated capillaries by CEC were negative, we employed 
polyacrylamide-coated capillary for the determination of the migration times of 
peptide fragments (tm′) and EOF (teo′). From Figure 1 it can be seen that sulfate groups, 
all still present in the covalently bonded heparin coating, play an important role 
especially in the heparin interaction with the 19 amino acid peptide. 
 
QCM technique has been successfully applied for the elucidation of various biological 




study, we employed QCM as a complementary technique to clarify the affinity 
between heparin and the 19 amino acid peptide of apoB-100 and the 15 amino acid 
peptide of apoE. Investigations were done at 25 °C and 37 °C. The frequency shifts 
recorded are presented in Figure 2. Scatchard plots were linear, and the Scatchard plot 
analysis exploited for calculation of the affinity constants (Ka) showed the 
repeatability of the technique to decrease at physiological temperature 37 °C (see 
Figure 3 and the 19 amino acid peptide). The slope of the plot of ∆f/C vs ∆f gives the 
Ka value for the system, where ∆f is the frequency shift and C is the concentration of 
the injected analyte. The concentration of the analytes ranged from 13 mg/mL to 50 
mg/mL for the 15 amino acid peptide of apoE and from 8 mg/mL to 40 mg/mL for the 
19 amino acid peptide of apoB-100. Each concentration point was run three times and 
RSD values were calculated (Table 2). The interaction between the positive peptides 
and heparin was described as log Ka values (Table 2). Surprisingly, the interaction of 
the 19 amino acid peptide of Apo B with charge of +6 was stronger than that of the 15 
amino acid peptide of ApoE with charge of +7. It could be that, if heparin does not 
totally cover the APTES–coated silica chip surface, positive charges of APTES also 
take part in the interaction. 
 
The retention factors obtained for peptide fragments by CEC showed the interactions 
for the 15 amino acid peptide of apoE with heparin to be at the same level in the 
APTES–heparin non-covalently coated and the APTES–heparin covalently coated 
capillaries. In contrast, the interactions of the 19 amino acid peptide of apoB-100 with 
heparin in the APTES–heparin covalently coated capillary were about twice as strong 
as those in the APTES–heparin non-covalently coated capillary. The log Ka values of 
5.22 and 5.02 at physiological temperature 37 °C and 5.54 and 5.20 at 25 °C obtained 
by QCM for the 19 amino acid peptide of apoB-100 and the 15 amino acid peptide of 
apoE, respectively, showed the interaction of the 19 amino acid peptide with heparin 





In the case of the APTES–heparin covalent coating, carboxylic groups were 
covalently bound to amino groups of APTES, while sulfate groups were free on the 
surface available for interaction. On the APTES–heparin non-covalent coating, in turn, 
both carboxylic and sulfate group took part in the electrostatic interaction between 
heparin and APTES, resulting in fewer sulfate and more carboxylic groups on the 
heparin surface. The stronger affinity of 19 amino acid peptide of apoB-100 to 
covalently attached heparin suggests that sulfate groups play a more important role 
than carboxylic groups. The weaker affinity of the 15 amino acid peptide of apoE 
towards heparin was seemingly not affected by the number of carboxylic and sulfate 
groups. Our results for the 15 amino acid peptide of apoE, with log Ka 5.20 at 25 oC 
and 5.02 at 37 oC, are in good agreement with those obtained by Futamura et al. [35], 
who report log Ka-value of 5.59 for the 22 kDa peptide fragment of apoE3 allele, 5.80 
for the 10 kDa peptide fragment of apoE and 7.66 for apoE. Our log Ka values were 
slightly higher, probably due to differences in the heparin immobilization technique 
and the shorter peptide we used. When Futamura et al. [35] used biotinylated heparin, 
no carboxylic groups were lost. Moreover, our previous studies, carried out by partial 
filling technique in affinity capillary electrophoresis, showed that when both negative 
sulfate groups and carboxyl groups of chodroitin-6-sulfate are available in the 
interaction, both peptides interact fairly strongly with C6S, and the shorter 15 amino 
acid peptide slightly more strongly[16]. 
 
3.3. Heparin interactions with human plasma lipoproteins and apoE studied by 
CEC  
The suitability of capillary electrochromatography for interaction studies of heparin 
with biomacromolecules was investigated with capillaries coated with heparin 
covalently bound on APTES-modified surfaces. In addition, because we wanted to 




and pure full-length apoE were investigated as well. Physiological conditions were 
mimicked by carrying out the experiments at pH 7.4 and 37˚C. The reduced mobilities 
that Kenndler [36] introduced to express the effect of the EOF on all separation 
relevant parameters for CE were used to clarify the relative interactions. The reduced 
mobility µi is given by                           
              (4) 
    
where µeff is the effective electrophoretic mobility of the analyte and µeo is the EOF in 
the coated capillary.  
 
Figure 4 demonstrates that all the biomolecules, except for HDL without apoE, 
interact more strongly with heparin-coated capillaries than with uncoated capillaries. 
Since the affinity towards heparin decreased in the order apoE-containing HDL > 
apoE > HDL without apoE, it is clear that apoE plays an important role in the 
interactions between HDL and heparin. This is in agreement with previous studies [6]. 
Multiple binding sites in HDL, or the presence of a more favourable lipid-induced 
conformation of apoE on HDL, may be responsible for the stronger heparin 
interactions of apoE when it is located on the HDL particle surface than when it is 
free in solution [7].  
 
Sulfate groups played a more important role than carboxylic groups in the interaction 
of heparin with LDL, as was also the case in the interaction of heparin with 19 amino 
acid peptide of apoB-100 described above. This was evident in the reduced mobility 
of LDL: the mobility of LDL in capillaries with APTES–heparin non-covalent coating, 
where most of the carboxylic and sulfate groups were lost through electrostatic 
interactions with APTES, was about one half that in capillaries with APTES–heparin 







Heparin coatings were applied to fused silica capillary modified with APTES. Both 
APTES–heparin non-covalent and APTES–heparin covalent coatings were 
successfully used for interaction studies between heparin and selected peptide 
fragments of apolipoproteins, human plasma lipoproteins, and apoE. The protocol for 
the coating where heparin was covalently attached to the APTES-modified silica 
capillary was also employed in immobilization of a SiO2 chip surface used in QCM 
studies. The differences between the covalent and non-covalent coatings revealed the 
important role of the sulfate groups in the interactions between heparin and peptide 
fragments. The interactions and affinity were expressed in CEC as retention factors 
and reduced mobilities and in QCM studies as affinity constants. The methods 
developed allowed highly efficient and easy characterization of the interactions under 
different conditions. The results were in a good agreement with earlier findings in 
regard to the importance of apoE in the interactions of HDL with proteoglycans. The 
CEC method developed was not only simple but it enabled studies with very low 
sample and reagent consumption. The QCM technique acted as a reliable 
complementary tool for CEC, with drawbacks, however, of relatively low heparin 
surface stability on expensive SiO2 chips. 
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Figure Legends  
 
Figure 1. Retention factors of peptide fragments.  : APTES–heparin covalently 
coated capillary;  : APTES–heparin non-covalently coated capillary. 
 
Figure 2. Frequency shifts recorded with Attester© for apoB-100 A) at 25 °C and B) 
at 37 °C and for 15 amino acid peptide of apoE C) at 25 °C and D) at 37 °C.  
 
Figure 3. Scatchard plots for 19 amino acid peptide of apoB-100 A) at 25 °C and B) 
at 37 °C.  
 
Figure 4. Reduced mobilities of macromolecules. : uncoated capillary;  : 
APTES–heparin covalently coated capillary;  : APTES–heparin non-covalently 


























Table 1. Coating to coating reproducibility (n=3) measured at 25˚C and 37˚C for three 
different capillaries with APTES-heparin non-covalent coatings, and at 37˚C with 











Capillary 1 5.58 (0.4%) 5.88 (4.5%) 6.16 (1.2%) 
Capillary 2 5.18 (3.9%) 5.95 (2.2%) 6.18 (0.6%) 








Table 2. Affinity constants expressed as log Ka obtained by QCM technique for 19 
amino acid peptide of apoB and 15 amino acid peptide of apoE at 25 °C and 37 °C. 
RSD values between different concentration points are in parenthesis.  
Temperature [°C] ApoB 19 aa ApoE 15 aa 
25 5.54 
[0.48-2.17%] 
5.20 
[0.71-3.41%] 
37 5.22 
[0.31-1.42%] 
5.02 
[6.52-13.09%] 
 
 
 
 
